BiBBInstruments AB carries out a directed share issue of SEK 10.0 million
The Board of Directors of the cancer diagnostics company BiBBInstruments AB (publ) ("BiBB" or the "Company") has, based on the authorization granted by the Annual General Meeting on 14 June 2023, resolved to carry out a directed share issue of approximately SEK 10.0 million directed to existing major shareholders. Existing owners include Tibia Konsult, Swedencare Entrepreneurs, the Aktia Nordic Micro Cap fund, and Herenco Group owner Lovisa Hamrin. The net proceeds will primarily be used for continued clinical evaluation of EndoDrill[®] GI in the USA and Europe, as well as for preparations